41 Results

People

  1. Rosen
    Rosen
  2. Solit
    Solit
  3. Larson
    Larson
  4. Scher
    Scher
  5. Hudis
    Hudis
  6. Modi
    Modi
  7. Ma
    Ma
  8. Morris
    Morris
  9. Slovin
    Slovin
  10. Yaeger
    Yaeger

Groups

  1. Breast Medicine Service (41)
  2. Department of Medicine (41)
  3. GSK Faculty (41)
  4. Molecular Pharmacology and Chemistry Program Faculty (41)
  5. Radiology, Department of (41)
  6. Sloan Kettering Institute Faculty (41)
  7. Solid Tumor Oncology Division (41)
  8. Human Oncology and Pathogenesis Program (31)
  9. Genitourinary Oncology Service (27)
  10. Body Imaging Service (18)
  1. "Neal Rosen"
  2. "Radiology, Department of"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (17)
Groups
  1. Breast Medicine Service (41)
  2. Department of Medicine (41)
  3. GSK Faculty (41)
  4. Molecular Pharmacology and Chemistry Program Faculty (41)
  5. Radiology, Department of (41)
  6. Sloan Kettering Institute Faculty (41)

More Groups

People
  1. Neal Rosen (41)
  2. David Solit (21)
  3. Steven Larson (15)
  4. Howard Scher (11)
  5. Clifford Hudis (7)
  6. Shanu Modi (7)

More People

Years
  1. 2022 (2)
  2. 2020 (1)
  3. 2019 (4)
  4. 2018 (2)
  5. 2015 (5)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Clinical Cancer Research (6)
  3. Cancer Research (5)
  4. Cancer Discovery (4)
  5. Journal of Nuclear Medicine (2)
  6. Nature Biotechnology (2)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. American Society of Clinical Oncology (9)
  3. Nature Publishing Group (3)
  4. Springer (3)
  5. Oxford University Press (2)
  6. Society of Nuclear Medicine (2)

More Publishers

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
    Journal Article

    Su, W.; Mukherjee, R.; Yaeger, R.; Son, J.; Xu, J.; Na, N.; Timaul, N. M.; Hechtman, J.; Paroder, V.; Lin, M.; more...
    Molecular Cell (2022)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
    Journal Article

    Arbour, K. C.; Manchado, E.; Bott, M. J.; Ahn, L.; Tobi, Y.; Ni, A. A.; Yu, H. A.; Shannon, A.; Ladanyi, M.; Perron, V.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • ARAF activates RAS by antagonizing its interaction with NF1
    Meeting Abstract

    Su, W.; Yaeger, R.; Na, N.; Hechtman, J.; Paroder, V.; Misale, S.; Han, S. W.; Abdel-Wahab, O. I.; McCormick, F.; Rosen, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • V211D mutation in MEK1 causes resistance to MEK inhibitors in colon cancer
    Journal Article

    Gao, Y.; Maria, A.; Na, N.; da Cruz Paula, A.; Gorelick, A. N.; Hechtman, J. F.; Carson, J.; Lefkowitz, R. A.; Weigelt, B.; Taylor, B. S.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Efficacy of MEK inhibition in patients with histiocytic neoplasms
    Journal Article

    Diamond, E. L.; Durham, B. H.; Ulaner, G. A.; Drill, E.; Buthorn, J.; Ki, M.; Bitner, L.; Cho, H.; Young, R. J.; Francis, J. H.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Meeting Abstract

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF(V600E)-mutant brain tumor
    Journal Article

    Wang, J.; Yao, Z.; Jonsson, P.; Allen, A. N.; Qin, A. C. R.; Uddin, S.; Dunkel, I. J.; Petriccione, M.; Manova, K.; Haque, S.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications
    Journal Article

    Rathkopf, D. E.; Larson, S. M.; Anand, A.; Morris, M. J.; Slovin, S. F.; Shaffer, D. R.; Heller, G.; Carver, B.; Rosen, N.; Scher, H. I.
    Cancer (2015)

    Fulltext@MSK | Save